Phase III Study of AZD7442 for Treatment of COVID-19 in Outpatient Adults
NCT04723394
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
910
Enrollment
INDUSTRY
Sponsor class
Conditions
COVID-19
Interventions
DRUG:
AZD7442
DRUG:
Placebo
Sponsor
AstraZeneca